Related Experiment Video
Updated: Oct 1, 2025
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
26.0K
Discovery of a functionally selective ghrelin receptor (GHSR1a) ligand for modulating brain dopamine
1Department of Cell Biology, Duke University Medical Center, Durham, NC 27710.
Summary
Researchers discovered N8279, a novel molecule that selectively targets the growth hormone secretagogue receptor-1a (GHSR1a) pathway. This discovery offers a promising approach for treating brain disorders linked to metabolism, aging, and addiction.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Growth hormone secretagogue receptor-1a (GHSR1a) signaling influences metabolism, aging, and addiction.
- GHSR1a activation involves distinct G protein- and β-arrestin-dependent pathways.
- Pathway-selective modulation is key for developing effective therapeutics with fewer side effects.
Purpose of the Study:
- To discover a brain-penetrant small molecule that selectively modulates GHSR1a signaling.
- To identify a compound that biases GHSR1a toward specific signaling pathways.
- To evaluate the therapeutic potential of the novel compound in preclinical models.
Main Methods:
- Discovery of a novel small molecule, N8279 (NCATS-SM8864).
- Assessment of N8279's ability to bias GHSR1a conformations.
- Evaluation of N8279's effects on dopaminergic behavior in mice.
Main Results:
- N8279 was identified as a brain-penetrant small molecule.
- N8279 selectively biases GHSR1a toward Gαq activation.
- N8279 reduced aberrant dopaminergic behavior in a mouse model.
Conclusions:
- N8279 is a promising chemical scaffold for developing novel therapeutics.
- Selective GHSR1a modulation offers a strategy for treating brain disorders.
- N8279 shows potential for treating conditions involving dopamine dysregulation.
More Related Videos
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
8.7K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.8K
Related Concept Videos
01:30Regulation of Food Intake
764
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
764
01:15G Protein-coupled Receptors
13.8K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.8K
01:09GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
01:24Glucagon-like Receptor Agonists
457
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
457
01:21G-protein Coupled Receptors
122.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
122.6K
01:12GPCR Desensitization
6.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.7K